BBL Shares Brisbane Broncos Limited
ASX · ASXLast in our picks 2026-10-22 — not in the current list; analysis below is from that screen
Autism diagnostic readout offers a near-term clinical value inflection point.
Future value: $1.76 (+20.14%) · 6-12 months
Signal breakdown
- ▸Upcoming autism results and speculative BUY rating
- ▾Below 50-day MA (-4.72%)
- ▸~20% upside to price target
Is BBL a buy right now?
Trend: BBL is trading below the 50-day average (-6.45%), RSI 52 — neutral momentum, with a 3-month return of +15.54%.
Valuation & quality: Brisbane Broncos Limited trades on a trailing P/E of 14.5, price-to-book 2.42; fundamentals show net margin 11.5%, return on equity 17.7%, revenue growth 27.2% year on year.
Income: trailing dividend yield 1.38%.
Our screen: ACCUMULATE (score 1) — Autism diagnostic readout offers a near-term clinical value inflection point.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -2.40% | +3.60% | +1.20% | -23.00% | -6.00% | +27.00% | +0.00% | -9.40% |
Fundamentals
Technical signals
About Brisbane Broncos Limited
Brisbane Broncos Limited, together with its subsidiaries, is involved in the management and operation of the Brisbane Broncos Rugby League Football teams in Australia. Brisbane Broncos Limited was incorporated in 1987 and is headquartered in Red Hill, Australia.
Sector: Communication Services · Industry: Entertainment · Australia · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.